Skip to main content

Covid vaccine maker CureVac in talks to sell 405M doses

The biotech is in discussions to provide up to 405 million doses of its experimental drug to European countries.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.